Hehlmann R, Lauseker M, Saussele S. et al. Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase. ASH 59th Annual Meeting & Exhibition, abstract 897.
Anti-BCMA CAR-T-celtherapie bb2121 bij multipel myeloom
jul 2019 | MM